Skip to main content
      T cells are known to play a key role in RA pathogenesis and the diversity of the T cell repertoire is known to be reduced in RA. 
      There is a clear unmet need for new and effective therapies in primary Sjogren’s Syndrome (pSS) patients, as there are no current licensed therapies.  
      The future of lupus treatment is oral therapies?

      There has been an explosion of trials in SLE, including nonrenal and

      Dr. John Cush RheumNow

      1 year 5 months ago
      The future of lupus treatment is oral therapies? There has been an explosion of trials in SLE, including nonrenal and glomerulonephritis studies. @Janetbirdope https://t.co/IQ9bxbTSV4 https://t.co/jVYOphxpAE
      RT @synovialjoints: In an early SpA (DESIR) cohort, the occurrence of a first pregnancy did not seem to increase the num

      Dr. Antoni Chan synovialjoints

      1 year 5 months ago
      In an early SpA (DESIR) cohort, the occurrence of a first pregnancy did not seem to increase the number of imaging abnormalities of the SIJ. Overall no significant changes in radiographic and MRI imaging abnormalities of the SIJ, Molto A, Abst#POS0303, #EULAR2023 @RheumNow
      RT @AurelieRheumo: Supervised 12 weeks High-intensity interval training program

      Improves Vo2 peak in IA patients

      But

      Aurelie Najm AurelieRheumo

      1 year 5 months ago
      Supervised 12 weeks High-intensity interval training program Improves Vo2 peak in IA patients But does not improve pain or fatigue It is disappointing but it is also a small study w/ n=30 pts in each group. It is unclear if the type of exercise has an impact on outcome https://t.co/Plk7sflrh5
      RT @AurelieRheumo: What happens when an AI-based symptom checker & an online self-referral tool play Rheumatologists

      Aurelie Najm AurelieRheumo

      1 year 5 months ago
      What happens when an AI-based symptom checker & an online self-referral tool play Rheumatologists? They don't seem to do great yet! 600 new pts, outw/ 36% dvlpd IA IA Sens 62% Spe 47% Tool Sens 66% Spe 54% More work needed to implement these in practice #EULAR23 @Rheumnow
      RheumNow’s expanded coverage of the #EULAR2023 meeting is sponsored in part by Bristol Myers Squibb. All content is c

      Dr. John Cush RheumNow

      1 year 5 months ago
      RheumNow’s expanded coverage of the #EULAR2023 meeting is sponsored in part by Bristol Myers Squibb. All content is chosen by RheumNow and its faculty.
      AOSD: Young vs. Elderly Onset

      AOSDis an autoinflammatory condition characterized by fevers, arthritis, and rash. It is

      Dr. John Cush RheumNow

      1 year 5 months ago
      AOSD: Young vs. Elderly Onset AOSDis an autoinflammatory condition characterized by fevers, arthritis, and rash. It is considered an orphan disease because of its low prevalence - it is reported anywhere between 16 to 40 per ten million. https://t.co/PPI1fvwLAf https://t.co/qMXMsbpwl3
      RT @drALINAdima: Top Influencers of #EULAR2023 👉 @eular_org @EMEUNET @RheumNow @ARD_BMJ @drdavidliew @Janetbirdope ht

      Alina DIMA drALINAdima

      1 year 5 months ago
      Top Influencers of #EULAR2023 👉 @eular_org @EMEUNET @RheumNow @ARD_BMJ @drdavidliew @Janetbirdope https://t.co/uUJM6tW824 via @symplur